DK65575A - - Google Patents

Info

Publication number
DK65575A
DK65575A DK65575*#A DK65575A DK65575A DK 65575 A DK65575 A DK 65575A DK 65575 A DK65575 A DK 65575A DK 65575 A DK65575 A DK 65575A
Authority
DK
Denmark
Application number
DK65575*#A
Other languages
Danish (da)
Other versions
DK153919C (da
DK153919B (da
Inventor
J M Indelicato
J M Greene
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23765656&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK65575(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK65575A publication Critical patent/DK65575A/da
Publication of DK153919B publication Critical patent/DK153919B/da
Application granted granted Critical
Publication of DK153919C publication Critical patent/DK153919C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK065575A 1974-02-22 1975-02-21 Fremgangsmaade til fremstilling af farmaceutiske kompositioner der indeholder toert natrium-7-(d-2-formyloxy-2-phenylacetamido)-3-(1-methyl-1h-tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylat DK153919C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US444622A US3928592A (en) 1974-02-22 1974-02-22 Antibiotic pharmaceutical compositions
US44462274 1974-02-22

Publications (3)

Publication Number Publication Date
DK65575A true DK65575A (ja) 1975-10-20
DK153919B DK153919B (da) 1988-09-26
DK153919C DK153919C (da) 1989-02-06

Family

ID=23765656

Family Applications (1)

Application Number Title Priority Date Filing Date
DK065575A DK153919C (da) 1974-02-22 1975-02-21 Fremgangsmaade til fremstilling af farmaceutiske kompositioner der indeholder toert natrium-7-(d-2-formyloxy-2-phenylacetamido)-3-(1-methyl-1h-tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylat

Country Status (24)

Country Link
US (1) US3928592A (ja)
JP (1) JPS6119605B2 (ja)
AR (1) AR203895A1 (ja)
AT (1) AT356264B (ja)
BE (1) BE825653A (ja)
CA (1) CA1043261A (ja)
CH (1) CH620929A5 (ja)
CS (1) CS189689B2 (ja)
DD (1) DD117807A5 (ja)
DE (1) DE2506622C2 (ja)
DK (1) DK153919C (ja)
ES (1) ES434976A1 (ja)
FR (1) FR2261772B1 (ja)
GB (1) GB1493676A (ja)
HU (1) HU174129B (ja)
IE (1) IE40671B1 (ja)
IL (1) IL46650A (ja)
NL (1) NL179976C (ja)
PH (1) PH12058A (ja)
PL (1) PL109311B1 (ja)
SE (1) SE406153B (ja)
SU (1) SU659094A3 (ja)
YU (1) YU41875A (ja)
ZA (1) ZA75975B (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4054738A (en) * 1975-12-22 1977-10-18 Eli Lilly And Company Sodium cefamandole crystalline forms
JPS5283956A (en) * 1976-01-01 1977-07-13 Lilly Co Eli Antibiotic method and medical composition
JPS5329936A (en) * 1976-08-31 1978-03-20 Takeda Chem Ind Ltd Antibiotic composition
JPS5711909A (en) * 1980-06-23 1982-01-21 Shionogi & Co Ltd Stable freeze-dried preparation of beta-lactam
NZ232763A (en) * 1989-03-06 1991-09-25 Lilly Co Eli Parenteral formulation comprising daptomycin with a buffer to maintain ph between 6.0 and 8.0
JP4873207B2 (ja) * 2001-02-26 2012-02-08 東レ・ファインケミカル株式会社 光学活性カルボン酸クロリドの精製方法
CN100554271C (zh) * 2007-07-27 2009-10-28 苏州中联化学制药有限公司 抗菌素头孢孟多酯钠的合成方法
CN101880290B (zh) * 2010-06-28 2012-03-07 海南新中正制药有限公司 头孢孟多酯钠的制备方法
WO2013057196A1 (en) * 2011-10-20 2013-04-25 Dsm Sinochem Pharmaceuticals Netherlands B.V. Process for the preparation of cefamandole nafate
WO2013057197A1 (en) * 2011-10-20 2013-04-25 Dsm Sinochem Pharmaceuticals Netherlands B.V. Process for the formylation of cefamandole
US9834567B1 (en) * 2014-12-16 2017-12-05 Tianjin University Crystalline form of cefamandole nafate compound, preparation and preparing method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1767891C3 (de) * 1968-06-28 1980-10-30 Pfizer Verfahren zur Herstellung von wäßrigen arzneilichen Lösungen für die parenterale, perorale und lokale Anwendung mit einem Gehalt an einem Tetracyclinderivat
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds

Also Published As

Publication number Publication date
PH12058A (en) 1978-10-18
JPS50126817A (ja) 1975-10-06
SE406153B (sv) 1979-01-29
BE825653A (fr) 1975-08-18
FR2261772B1 (ja) 1980-01-04
PL109311B1 (en) 1980-05-31
DE2506622A1 (de) 1975-08-28
IE40671B1 (en) 1979-07-18
GB1493676A (en) 1977-11-30
ZA75975B (en) 1976-09-29
AT356264B (de) 1980-04-25
HU174129B (hu) 1979-11-28
JPS6119605B2 (ja) 1986-05-17
IL46650A0 (en) 1975-05-22
DK153919C (da) 1989-02-06
AU7833975A (en) 1976-08-19
CA1043261A (en) 1978-11-28
CS189689B2 (en) 1979-04-30
SU659094A3 (ru) 1979-04-25
DD117807A5 (ja) 1976-02-05
IL46650A (en) 1977-10-31
DK153919B (da) 1988-09-26
DE2506622C2 (de) 1987-02-26
NL7502045A (nl) 1975-08-26
SE7501985L (ja) 1975-08-25
US3928592A (en) 1975-12-23
ATA128475A (de) 1979-09-15
IE40671L (en) 1975-08-22
YU41875A (en) 1982-05-31
ES434976A1 (es) 1976-12-16
CH620929A5 (ja) 1980-12-31
AR203895A1 (es) 1975-10-31
NL179976C (nl) 1986-12-16
FR2261772A1 (ja) 1975-09-19
NL179976B (nl) 1986-07-16

Similar Documents

Publication Publication Date Title
FR2494073B1 (ja)
DK675A (ja)
JPS50126817A (ja)
FR2264418B3 (ja)
FR2296032B2 (ja)
FR2267094A1 (ja)
FR2283306B2 (ja)
FR2266982A1 (ja)
AU495930B2 (ja)
FR2287299B1 (ja)
JPS50104059U (ja)
JPS50103928A (ja)
DD119708A1 (ja)
CH566915A5 (ja)
BG22156A1 (ja)
AU480471A (ja)
BG20451A1 (ja)
BG20446A1 (ja)
AU479765A (ja)
BG20440A1 (ja)
BG22114A1 (ja)
BG19987A1 (ja)
BG19847A1 (ja)
BG22571A1 (ja)
CH1163975A4 (ja)

Legal Events

Date Code Title Description
PUP Patent expired